Gender determinants of cardiovascular risk factors and diseases

Journal of Cardiovascular Medicine

Volumn 11, Issue 3, 2010, Pages 207-220

  Mercuro, Giuseppe ^a   Deidda, Martino ^a   Piras, Alessandra ^a   Dessalvi, Christian Cadeddu ^a   Maffei, Silvia ^b   Rosano, Giuseppe M C ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cardiovascular disease; Gender; Genetics; Pathophysiology; Sex hormones

Indexed keywords

ESTRADIOL; PROGESTERONE; TESTOSTERONE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; GENDER; GENETIC SUSCEPTIBILITY; HEART FAILURE; HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MORTALITY; POSTMENOPAUSE; PREVALENCE; REVIEW; SEX DIFFERENCE; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; ESTRADIOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; PROGESTERONE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TESTOSTERONE; YOUNG ADULT;

EID: 76449120222     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833178ed     Document Type: Review

References (161)

1. Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Ruiz Noppinger P. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med 2008; 86:61-74.
2. Ely D, Caplea A, Dunphy G, Turner M, Milsted A, Takiyyudin M, et al. Spontaneously hypertensive rat Y chromosome increases indexes of sympathetic nervous system activity. Hypertension 1997; 29:613-618.
3. Dumas P, Kren V, Krenova D, Pravenec M, Hamet P, Tremblay J, et al. Identification and chromosomal localization of ecogenetic components of electrolyte excretion. J Hypertens 2002; 20:209-217.
4. Ellis JA, StebbingM, Harrap SB. Association of the human Y chromosome with high BP in the general population. Hypertension 2000; 36:731-733.
5. Garcia EC, Gonzalez P, Castro MG, Alvarez R, Reguero JR, Batalla A, et al. Association between genetic variation in the Y chromosome and hypertension in myocardial infarction patients. Am J Med Genet A 2003; 122:234-237.
6. Charchar FJ, Tomaszewski M, Lacka B, Zakrzewski J, Zukowska- Szczechowska E, Grzeszczak W, Dominiczak AF. Association of the human Y chromosome with cholesterol levels in the general population. Arterioscler Thromb Vasc Biol 2004; 24:308-312.
7. Shoji M, Tsutaya S, Shimada J, Kojima K, Kasai T, Yasujima M. Lack of association between Y chromosome Alu insertion polymorphism and hypertension. Hypertens Res 2002; 25:1-3.
8. Ely D, Turner M, Milsted A. Review of the Y chromosome and hypertension. Braz J Med Biol Res 2000; 33:679-691.
9. Russo P, Siani A, Miller MA, Karanam S, Esposito T, Gianfrancesco F, et al. Genetic variants of Y chromosome are associated with a protective lipid profile in black men. Arterioscler Thromb Vasc Biol 2008; 28:1569-1574.
10. Bondy CA. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis 2008; 3:2-15.
11. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001; 86:4166-4170.
12. Lichiardopol C, Mota M. Cardiovascular risk factors in Turner syndrome. Rom J Intern Med 2004; 42:371-379.
13. Kyndt F, Le Scouarnec S, Jaafar P, Gueffet JP, Legendre A, Trochu JN, et al. Genetic aspects of valvulopathies. Arch Mal Coeur Vaiss 2007; 100:1013-1020.
14. Bernstein KE. Two ACEs and a heart. Nature 2002; 417:799-802.
15. Oudit GY, Crackower MA, Backx PH, Penninger JM. The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 2003; 13:93-101.
16. Labuda M, Uwabo J, Sun Y, Yamamoto M, Abe M, Chen Y, et al. Polymorphism in ACE2 gene is associated with hypertension and hypertension-related phenotypes in French-Canadians. Can J Cardiol 2004; 20 (Suppl D):48D.
17. Jin JJ, Nakura J, Wu Z, Gaudet D, Gossard F, Pausova Z, et al. Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26:547-552. (Pubitemid 36974997)
18. Ueno T, Tremblay J, Kunes J, Zicha J, Dobesová Z, Pausova Z, et al. Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. Physiol Res 2003; 52:689-700.
19. Moreno C, Dumas P, Kaldunski ML, Tonellato PJ, Greene AS, Roman RJ, et al. Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics 2003; 15:243-257.
20. Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, Kaldunski M, et al. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet 2005; 76:815-832.
21. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 2006; 38:218-222.
22. McArdle PF, Dytch H, O'Connell JR, Shuldiner AR, Mitchell BD, Abney M. Homozygosity by descent mapping of blood pressure in the Old Order Amish: evidence for sex specific genetic architecture. BMC Genet 2007; 8:66.
23. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002; 90 (1A):3F-6F.
24. Ropero AB, Eghbali M, Minosyan TY, Tang G, Toro L, Stefani E. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol 2006; 41:496-510.
25. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89:1943-1950.
26. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94:727-733.
27. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, et al. Oestradiol 17b attenuates acetylcholine induced coronary arterial constriction in women but not in men with coronary artery disease. Circulation 1995; 92:24-30.
28. Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995; 99:119-122.
29. Williams JK, Anthony MS, Honoré EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vas Biol 1995; 15:827-836.
30. Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerquetani E, et al. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause 2005; 12:552-558.
31. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pelliccia F, et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008; 28:348-352.
32. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43:985-991.
33. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523-534.
34. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006; 166:357-365. (Pubitemid 43244325)
35. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 2007; 49:1358-1363.
36. Goldstein J, Sites CK, Toth MJ. Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertil Steril 2004; 82:430-436.
37. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17bestradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol Heart Circ Physiol 1992; 263:H271-H275.
38. Miller VM, Giscard V, Vanhoutte PM. Modulation of endotheliumdependent and vascular smooth muscle responses by estrogens. Phlebologie 1988; 224:19-22.
39. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998; 98:256-261.
40. Schaible TF, Malhotra A, Ciambrone G, Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 1984; 54:38-49.
41. Curl CL, Wendt IR, Kotsanas G. Effects of gender on intracellular. Pflugers Arch 2001; 441:709-716.
42. Brouillette J, Trepanier-Boulay V, Fiset C. Effect of androgen deficiency on mouse ventricular repolarization. J Physiol 2003; 546:403-413.
43. Trepanier-Boulay V, St-Michel C, Tremblay A, Fiset C. Gender-based differences in cardiac repolarization in mouse ventricle. Circ Res 2001; 89:437-444.
44. Golden KL, Marsh JD, Jiang Y, Brown T, Moulden J. Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am J Physiol Endocrinol Metab 2003; 285:E449-E453.
45. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2003; 284:H1560-H1569.
46. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 1999; 34:920-923.
47. McGrath KC, McRobb LS, Heather AK. Androgen therapy and atherosclerotic CVD. Vasc Health Risk Manag 2008; 4:11-21.
48. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-1649.
49. Gupta SK, Lindemulder EA, Sathyan G. Modeling of circadian testosterone in healthy men and hypogonadal men. J Clin Pharmacol 2000; 40:731-738.
50. Celentano A, Palmieri V, Arezzi E, Mureddu GF, Sabatella M, Di Minno G, De Simone G. Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults. J Hypertens 2003; 21:1415-1423.
51. Burke JH,Goldberger JJ,Ehlert FA, Kruse JT,ParkerMA,KadishAH.Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996; 100:537-543.
52. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Prog Biophys Mol Biol 2007; 94:265-319.
53. Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997; 18:1000-1006.
54. Villareal RP, Woodroof AL, Massumi A. Gender and cardiac arrhythmias. Tex Heart Inst J 2001; 28:265-275.
55. Anthony M. Male/female differences in pharmacology: safety issues with QT-prolonging drugs. J Womens Health (Larchmt) 2005; 14:47-52.
56. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 1995; 25:242-249.
57. Rautaharju P, Kooperberg C, Larson J, Lacroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women. Circulation 2006; 113:473-480.
58. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD. Agerelated changes in normal human hearts during the first 10 decades of life. Part II (Maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 1988; 63:137-146.
59. Arbustini E, Morbini P, Dal Bello B, Specchia G. Aspetti anatomopatologici della cardiopatia ischemica nella donna. Cardiologia 1996; 41:227-232.
60. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93:1354-1363.
61. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, Virmani R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82:269-272.
62. Hackel DB, Wagner GS. Acute myocardial infarction with ventricular septal rupture. Clin Cardiol 1993; 16:143-146.
63. Basso C, Morgagni GL, Thiene G. Spontaneous coronary artery dissection: a neglected cause of acute myocardial ischemia and sudden death. Heart 1996; 75:451-454.
64. Geelen G, Laitinen T, Hartikainen J, Bergstrom K, Niskanen L. Gender influence on vasoactive hormones at rest and during a 70 degree head-up tilt in healthy humans. J Appl Physiol 2002; 92:1401-1408.
65. Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL, et al. Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension 1999; 33:1195-1200.
66. Bar-Or O, Shephard RJ, Allen CL. Cardiac output of 10- to 13-year-old boys and girls during submaximal exercise. J Appl Physiol 1971; 30:219-223.
67. Saba MM, Ibrahim MM, Rizk HH. Gender and the relationship between resting heart rate and left ventricular geometry. J Hypertens 2001; 19:367-373.
68. Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8:978-986.
69. Pines A. Hormone therapy and the cardiovascular system. Maturitas 2002; 43 (Suppl 1):S3-S10.
70. Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 1999; 84:606-610.
71. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90:786-791.
72. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995; 26:1068-1079.
73. Pfeffer JM, Pfeffer MA, Fletcher P, Braunwald E. Alterations of cardiac performance in rats with established spontaneous hypertension. Am J Cardiol 1979; 44:994-998.
74. Carroll JD, Carroll EP, Feldman T, Lang RM, McGaughey D, Karp RB. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992; 86:1099-1107.
75. Gerdts E, Zabalgoitia M, Björnstad H, Svendsen TL, Devereux RB. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy. Am J Cardiol 2001; 87:980.
76. Crabbe DL, Dipla K, Zaferiridis A, Gaughan JP, Houser SR, Margulies KB. Gender differences in postinfarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 2003; 41:300-306.
77. Troiano RP, Briefel RR, Carroll MD, Bialostosky K. Energy and fat intakes of children and adolescents in the United States: data from the National Health and Nutrition Examination Surveys. Am J Clin Nutr 2000; 72:1343S-1353S.
78. Veugelers PJ, Fitzgerald AL, Johnston E. Dietary intake and risk factors for poor diet quality among children in Nova Scotia. Can J Public Health 2005; 96:212-216.
79. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 2000; 320:1240-1243.
80. Kelder SH, Osganian SK, Feldman HA, Webber LS, Parcel GS, Leupker RV, Wu MC, et al. Tracking of physical and physiological risk variables among ethnic subgroups from third to eighth grade: the Child and Adolescent Trial for Cardiovascular Health cohort study. Prev Med 2002; 34:324-333.
81. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 2002; 288:1723-1727.
82. Kim S, Popkin BM. Commentary: understanding the epidemiology of overweight and obesity: a real global public health concern. Int J Epidemiol 2006; 35:60-67.
83. Crawford SL, Casey VA, Avis NE, McKinlay SM. A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 2000; 7:96-104.
84. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, De Simone L, Genazzani AR. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999; 2:37-44.
85. Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002; 81:603-611.
86. Nader PR. National Institute of Child Health and Human Development Study of Early Child Care and Youth Development Network. Frequency and intensity of activity of third-grade children in physical education. Arch Pediatr Adolesc Med 2003; 157:185-190.
87. Maia JA, Thomis M, Beunen G. Genetic factors in physical activity levels: a twin study. Am J Prev Med 2002; 23:87-91.
88. Marshall SJ, Gorely T, Biddle SJ. A descriptive epidemiology of screenbased media use in youth: a review and critique. J Adolesc 2006; 29:333-349.
89. Pitsavos C, Panagiotakos D, Lentzas Y, Stefanadis C. Epidemiology of leisure-time physical activity in socio-demographic, lifestyle and psychological characteristics of men and women in Greece: the ATTICA Study. BMC Public Health 2005; 5:37.
90. Gal DL, Santos AC, Barros H. Leisure-time versus full-day energy expenditure: a cross-sectional study of sedentarism in a Portuguese urban population. BMC Public Health 2005; 5:16.
91. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. J Am Med Assoc 1989; 262:2395-2401.
92. U.S. Dept of Health and Human Services. Physical Activity and Health: a Report of the Surgeon General. Atlanta, GA: U.S. Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease prevention and Health Promotion; 1996.
93. Karp I, O'Loughlin J, Paradis G, Hanley J, Difranza J. Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use. Ann Epidemiol 2005; 15:445-452.
94. Makomaski Illing EM, Kaiserman MJ. Mortality attributable to tobacco use in Canada and its regions, 1998. Can J Public Health 2004; 95:38-44.
95. Rigotti NA, Pasternak RC. Cigarette smoking and coronary heart disease: risks and management. Cardiol Clin 1996; 14:51-68.
96. Economides D, Braithwaite J. Smoking, pregnancy and the fetus. J R Soc Health 1994; 114:198-201.
97. Bolumar F, Olsen J, Boldsen J. Smoking reduces fecundity: a European multicenter study on infertility and subfecundity. The European Study Group on Infertility and Subfecundity. Am J Epidemiol 1996; 143:578-587.
98. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990; 97:588-594.
99. Hays JT, Hurt RD, Dale LC. Smoking cessation. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, editors. Prevention of myocardial infarction. New York, NY: Oxford University Press; 1996. pp. 99-129.
100. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, et al. The primary prevention of myocardial infarction. N Engl J Med 1992; 326:1406-1416.
101. Bolego C, Poli A, Paoletti R. Smoking and gender. Cardiovasc Res 2002; 53:568-576.
102. Schmeiser-Rieder A, Schoberberger R, Kunze M. Women and smoking. Wien Med Wochenschr 1995; 145:73-76.
103. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Prev Med 1994; 23:190-196.
104. Samet JM. The health benefits of smoking cessation. Med Clin North Am 1992; 76:399-414.
105. Weintraub WS. Cigarette smoking as a risk factor for coronary artery disease. Adv Exp Med Biol 1990; 273:27-37.
106. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153:2209-2216.
107. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. J Am Med Assoc 1993; 269:3002-3008.
108. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett- Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association Writing Group. Circulation 1997; 96:2468-2482.
109. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990; 12:321-331.
110. Austin M, Breslow J, Hennekens C, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988; 260:1917-1921.
111. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12:187-195.
112. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-1 and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104:1108-1113.
113. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79:8-15.
114. Li Z, McNamara JR, Fruchart JC, Luc G, Bard JM, Ordovas JM, et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 1996; 37:1886-1896.
115. Campos H, McNamara JR, Wilson PW, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988; 67:30-35.
116. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98:83-90.
117. Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol 1995; 75:53B-57B.
118. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-219.
119. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995; 123:673-675.
120. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992; 85:889-896.
121. Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. J Am Med Assoc 2000; 283:1845-1852.
122. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993; 87:1135-1141.
123. Paradis G, Lambert M, O'Loughlin J, Lavallée C, Aubin J, Delvin E, et al. Blood pressure and adiposity in children and adolescents. Circulation 2004; 110:1832-1838.
124. Genovesi S, Giussani M, Pieruzzi F, Vigorita F, Arcovio C, Cavuto S, Stella A. Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight. J Hypertens 2005; 23:493-497.
125. Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 2001; 4:10-13.
126. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J Am Med Assoc 2003; 289:2363-2369.
127. Ellis JA, Wong ZY, Stebbing M, Harrap SB. Sex, genes and blood pressure. Clin Exp Pharmacol Physiol 2001; 28:1053-1055.
128. Whelton PK, He J, Appel LJ. Treatment and prevention of hypertension. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, editors. Prevention of myocardial infarction. New York, NY: Oxford University Press; 1996. pp. 154-171.
129. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K, DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47:2118-2128.
130. Walton C, Godsland I, Proudler A, Wynn V, Stevenson JC. The effects of the menopause on carbohydrate metabolism in healthy women. J Endocrinol 1991; 129:A97.
131. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000; 101:2040-2046.
132. Sowers JR. Insulin and insulin-like growth factors in normal and pathologic cardiovascular physiology. Hypertension 1997; 29:691-699.
133. Wexler D, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in the treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28:514-520.
134. Peterson S, Peto V, Rayner M, Luengo-Fernandez R, Gray A. European Cardiovascular Disease Statistics. 2nd ed. London: British Heart Foundation; 2005.
135. Heart disease and stroke statistics-2005 Update. Dallas, TX: American Heart Association; 2004.
136. Lobo RA, Pickar JH, Wild RA. Metabolic impact of adding medroxiprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol 1994; 84:987-995.
137. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 1987; 258:1183-1186.
138. CASS. The Principal Investigators of CASS and Their Associates: The National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS). Circulation 1981; 63:1-81.
139. Kennedy JW, Killip T, Fisher LD, Alderman EL, Gillespie MJ, Mock MB, et al. The clinical spectrum of coronary artery disease and its surgical and medical management. The Coronary Artery Surgery Study. Circulation 1982; 66:16-23.
140. Birdwell BG, Herbers JE, Kroenke K. Evaluating chest pain: the patient's presentation style alters the physician's diagnostic approach. Arch Intern Med 1993; 153:1991-1995.
141. Cannon RO III, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992; 85:883-892.
142. Cardiovascular Health Branch, Division of Chronic Disease Control and Community Intervention, National Center for Chronic Disease Prevention and Health Promotion, CDC. Trends in ischemic heart disease mortality- United States, 1980-1988. Morb Mortal Week Rep 1992; 41:548-556.
143. Adams JN, Jamieson M, Rawles JM, Trent RJ, Jennings KP. Women and myocardialinfarction:agismratherthansexism?BrHeartJ1995;73:87-91.
144. Murabito JM. Women and cardiovascular disease: contributions from the Framingham Heart Study. J Am Med Wom Assoc 1995; 50:35-39.
145. Tofler GH, Stone PH, Muller JE, Willich SN, Davis VG, Poole WK, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. JACC 1987; 9:473-482.
146. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995; 91:1861-1871.
147. Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? JACC 1997; 29:35-42.
148. Polk DM, Naqvi TZ. Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation. Curr Cardiol Rep 2005; 7:166-172.
149. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. JACC 1995; 2:807-814.
150. Weiner DA, Ryan TJ,McCabe CH, Kennedy JW, Schloss M, Tristani F, et al. Exercise stress testing: correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med 1979; 301:230-235.
151. Reeves MJ, Bushnell CD, HowardG, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7:915-926.
152. MacClellan LR, Giles WH, Cole J, Wozniak MA, Stern B, Mitchell B, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women Study. Stroke 2007; 38:2438-2445.
153. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. J Am Med Assoc 2003; 289:2673-2684.
154. Warner Gargano J, Wehner S, Reeves MJ. Do presenting symptoms explain sex differences in emergency department delays among patients with acute stroke? Stroke 2009; 40:1114-1120.
155. Kurth T, Bousser MG. Stroke in women. An evolving topic. Stroke 2009; 40:1027-1028.
156. Frazier CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction. J Am Coll Cardiol 2007; 49:1450-1458.
157. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992; 117:502-510.
158. Cuocolo A, Sax FL, Brush JE, Bacharach SL, Bonow RO. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Circulation 1990; 81:978-986.
159. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87 (Suppl VI):VI5-V16.
160. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32:695-703.
161. Rathore SS, Foody JM, Wang Y, Herrin J, Masoudi FA, Havranek EP, et al. Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2005; 149:121-128 (Pubitemid 40126499)